Full name :
First name :
Mail :
Zip Code :
City :
Country :
Email :
Phone :
Fax :
Website :
Directory :
Title : Lipoprotein-Associated Phospholipase A2 Activity Is a Marker of Risk But Not a Useful Target for Treatment in Patients With Stable Coronary Heart Disease - Wallentin_2016_J.Am.Heart.Assoc_5_ |
Author(s) : Wallentin L , Held C , Armstrong PW , Cannon CP , Davies RY , Granger CB , Hagstrom E , Harrington RA , Hochman JS , Koenig W , Krug-Gourley S , Mohler ER, 3rd , Siegbahn A , Tarka E , Steg PG , Stewart RA , Weiss R , Ostlund O , White HD |
Ref : J Am Heart Assoc , 5 : , 2016 |
Abstract : Wallentin_2016_J.Am.Heart.Assoc_5_ |
ESTHER : Wallentin_2016_J.Am.Heart.Assoc_5_ |
PubMedSearch : Wallentin_2016_J.Am.Heart.Assoc_5_ |
PubMedID: 27329448 |
Title : Lipoprotein-associated phospholipase A(2) and risk of coronary disease, stroke, and mortality: collaborative analysis of 32 prospective studies - Thompson_2010_Lancet_375_1536 |
Author(s) : Thompson A , Gao P , Orfei L , Watson S , Di Angelantonio E , Kaptoge S , Ballantyne C , Cannon CP , Criqui M , Cushman M , Hofman A , Packard C , Thompson SG , Collins R , Danesh J |
Ref : Lancet , 375 :1536 , 2010 |
Abstract : Thompson_2010_Lancet_375_1536 |
ESTHER : Thompson_2010_Lancet_375_1536 |
PubMedSearch : Thompson_2010_Lancet_375_1536 |
PubMedID: 20435228 |